PetIQ Inc (PETQ)
30.75
+0.01
(+0.03%)
USD |
NASDAQ |
Sep 27, 16:00
30.76
+0.01
(+0.03%)
After-Hours: 20:00
PetIQ Revenue (Annual): 1.102B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.102B |
| December 31, 2022 | 921.51M |
| December 31, 2021 | 932.53M |
| December 31, 2020 | 780.05M |
| December 31, 2019 | 709.43M |
| Date | Value |
|---|---|
| December 31, 2018 | 528.61M |
| December 31, 2017 | 266.69M |
| December 31, 2016 | 200.16M |
| December 31, 2015 | 205.69M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
709.43M
Minimum
2019
1.102B
Maximum
2023
889.10M
Average
921.51M
Median
2022
Revenue (Annual) Benchmarks
| Omeros Corp | -- |
| BioCardia Inc | 0.477M |
| Revance Therapeutics Inc | 234.04M |
| Zevra Therapeutics Inc | 27.46M |
| Alector Inc | 97.06M |